• University of Surrey Featured Masters Courses
  • Aberystwyth University Featured Masters Courses
  • University of Derby Online Learning Featured Masters Courses
  • University of Edinburgh Featured Masters Courses
  • University of Bristol Featured Masters Courses
  • Jacobs University Bremen gGmbH Featured Masters Courses
  • Swansea University Featured Masters Courses
  • Northumbria University Featured Masters Courses
De Montfort University Featured Masters Courses
Xi’an Jiaotong-Liverpool University Featured Masters Courses
University of Bedfordshire Featured Masters Courses
University of Birmingham Featured Masters Courses
University of Nottingham Featured Masters Courses
"cancer" AND "therapeutic…×
0 miles

Masters Degrees (Cancer Therapeutics)

We have 46 Masters Degrees (Cancer Therapeutics)

  • "cancer" AND "therapeutics" ×
  • clear all
Showing 1 to 15 of 46
Order by 
This full-time MSc course is designed to provide graduates with advanced knowledge, understanding and skills in the rapidly advancing field of Cancer Biology and Therapeutics. Read more
This full-time MSc course is designed to provide graduates with advanced knowledge, understanding and skills in the rapidly advancing field of Cancer Biology and Therapeutics.

The course offers advanced teaching in the cellular aspects of cancer biology together with the molecular mechanisms underlying cancer development and progression. It provides in-depth training in cancer therapeutics, encompassing biomarkers and diagnosis, therapeutic targets, drug discovery and clinical trials and chemo/radio therapy, as well as aiming to develop your theoretical and practical research skills. This postgraduate programme offers a balanced combination of theory and practice that would serve as preparation for doctoral research or as a self-contained advanced qualification in its own right.

Graduates from this course should gain a breadth and depth of cancer-focused training that will make them highly attractive candidates to start or continue a career within the healthcare sector and research establishments.

The course offers research skills training and a laboratory-based research project that can provide you with the skills required to develop research hypotheses and critically evaluate translational approaches with respect to the development of contemporary cancer therapeutics.

Distinctive features

• A broad ranging course that covers basic molecular cancer cell biology through to translational research and therapeutics.

• A course developed in collaboration with researchers, academics and clinicians and delivered by leading academic cancer researchers at Cardiff University.

• Key lectures and case study workshops delivered by practising oncologists and cancer surgeons.

• Opportunity to study at Cardiff University, one of the UK’s major teaching and research universities.

• Opportunity to undertake a research project in one of the internationally recognized cancer research groups at Cardiff.

• Close academic support from an experienced personal tutor.
Opportunity to join a vibrant postgraduate community studying at Cardiff.

Structure

This is a full-time course over one academic year. You will study 180 credits: 120 of taught material, followed by a 60 credit project.

Core modules:

Data Handling and Statistics
Cellular and Molecular Biology of Cancer
Translational Oncology and Therapeutics
Academic Research Skills
Research Methodology
Research Project

Teaching

The programme will provide advanced teaching in the cellular aspects of cancer biology together with the molecular mechanisms underlying cancer development and progression. In-depth training will be provided in the area of cancer therapeutics, encompassing biomarkers and diagnosis, therapeutic targets, drug discovery and clinical trials and chemo/radio therapy, in addition to developing the student’s theoretical and practical research skills.

Assessment

Assessment for the course will comprise a combination of exams, written essays, posters, laboratory coursework and case studies.

Career Prospects

Graduates from this course should gain a breadth and depth of cancer-focused training that could make them highly attractive candidates to start or continue a career within the healthcare sector and research establishments.

Potential employment opportunities include PhD student, research technician, medical laboratory science officer, clinical trials co-ordinator, and medical writer.

Read less
The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. Read more

The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. The programme, taught by research scientists and academic clinicians, provides students with an in-depth look at the biology behind the disease processes which lead to cancer.

About this degree

This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students learn about the approaches taken to predict, detect, monitor and treat cancer, alongside the cutting-edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies.

Students undertake modules to the value of 180 credits.

The programme consists of two core modules (60 credits), four specialist modules (60 credits) and a research project (60 credits).

A Postgraduate Diploma (120 credits, full-time nine months) is offered.

A Postgraduate Certificate (60 credits, full-time 12 weeks) is offered.

Core modules

  • Basic Biology and Cancer Genetics
  • Cancer Therapeutics

Specialist modules

  • Behavioural Science and Cancer
  • Biomarkers in Cancer
  • Cancer Clinical Trials
  • Haematological Malignancies and Gene Therapy

Dissertation/report

All MSc students undertake a laboratory project, clinical trials project or systems biology/informatics project, which culminates in a 10,000–12,000 word dissertation and an oral research presentation.

Teaching and learning

Students develop their knowledge and understanding of cancer through lectures, self-study, database mining, wet-lab based practicals, clinical trial evaluations, laboratory training, assigned reading and self-learning. Each taught module is assessed by an unseen written examination and/or coursework. The research project is assessed by the dissertation (75%) and oral presentation (25%).

Further information on modules and degree structure is available on the department website: Cancer MSc

Careers

The knowledge and skills developed will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating a PhD or medical studies in cancer.

Employability

Skills include critical evaluation of scientific literature, experimental planning and design interpretation of data and results, presentation/public speaking skills, time management, working with a team, working independently and writing for various audiences.

Why study this degree at UCL?

UCL is one of Europe's largest and most productive centres of biomedical science, with an international reputation for leading basic, translational and clinical cancer research.

The UCL Cancer Institute brings together scientists from various disciplines to synergise multidisciplinary research into cancer, whose particular areas of expertise include: the biology of leukaemia, the infectious causes of cancer, the design of drugs that interact with DNA, antibody-directed therapies, the molecular pathology of cancer, signalling pathways in cancer, epigenetic changes in cancer, gene therapy, cancer stem cell biology, early phase clinical trials, and national and international clinical trials in solid tumours and blood cancers.

Research Excellence Framework (REF)

The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.

The following REF score was awarded to the department: Cancer Institute

80% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)

Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.



Read less
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of treating cancer. Read more
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of treating cancer.

This will be underpinned by a thorough knowledge of cancer biology and pathology and research methodologies.

This knowledge will provide an excellent grounding in the development, use and evaluation of cancer therapies, which will enhance career prospects in many areas of early phase clinical trials and clinical drug development in the cancer setting.

Compulsory Modules

• Ablative Therapies
• Cancer Biology
• Cancer Pharmacology
• Cancer Prevention & Screening
• Drug Development
• Molecular Diagnostic & Therapeutics
• Molecular Targeted Therapies and Immunotherapy for Blood Cancer
• Research Methods
• Site Specific Tumour Treatment

Elective Modules

• Genomic Approaches to Human Diseases
• Paediatric & Adolescent Oncology
• Pathology of Cancer

Core Module for MSc

• Dissertation.

Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, our programmes are all taught by experts in the field.

Find out more about the BCI at http://www.bci.qmul.ac.uk/study-with-us

Read less
The MSc in Cancer Biology is for students who wish to gain an advanced education and training in the biological sciences, within the context of a disease that affects a large proportion of the global population. Read more
The MSc in Cancer Biology is for students who wish to gain an advanced education and training in the biological sciences, within the context of a disease that affects a large proportion of the global population.

The programme provides training in the modern practical, academic and research skills that are used in academia and industry. Through a combination of lectures, small-group seminars and practical classes, students will apply this training towards the development of new therapies.

The programme culminates with a research project that investigates the molecular and cellular basis of cancer biology or the development of new therapies under the supervision of active cancer research scientists.

Visit the website: https://www.kent.ac.uk/courses/postgraduate/226/cancer-biology

About the School of Biosciences

The School of Biosciences is among the best-funded schools of its kind in the UK, with current support from the BBSRC, NERC, MRC, Wellcome Trust, EU, and industry. It has 38 academic staff, 56 research staff (facility managers, research fellows, postdoctoral researchers and technicians), approximately 100 postgraduate students and 20 key support staff. The school's vibrant atmosphere has expanded to become a flourishing environment to study for postgraduate degrees in a notably friendly and supportive teaching and research environment.

Research in the School of Biosciences revolves around understanding systems and processes in the living cell. It has a strong molecular focus with leading-edge activities that are synergistic with one another and complementary to the teaching provision. Our expertise in disciplines such as biochemistry, microbiology and biomedical science allows us to exploit technology and develop groundbreaking ideas in the fields of genetics, molecular biology, protein science and biophysics. Fields of enquiry encompass a range of molecular processes from cell division, transcription and translation through to molecular motors, molecular diagnostics and the production of biotherapeutics and bioenergy.

In addition to research degrees, our key research strengths underpin a range of unique and career-focused taught Master’s programmes that address key issues and challenges within the biosciences and pharmaceutical industries and prepare graduates for future employment.

Course structure

Each one-hour lecture is supplemented by two hours of small-group seminars and workshops in which individual themes are explored in-depth. There are practical classes and mini-projects in which you design, produce and characterise a therapeutic protein with applications in therapy.

In additional to traditional scientific laboratory reports, experience will be gained in a range of scientific writing styles relevant to future employment, such as literature reviews, patent applications, regulatory documents, and patient information suitable for a non-scientific readership.

Modules

The following modules are indicative of those offered on this programme. This list is based on the current curriculum and may change year to year in response to new curriculum developments and innovation. Most programmes will require you to study a combination of compulsory and optional modules. You may also have the option to take modules from other programmes so that you may customise your programme and explore other subject areas that interest you.

BI830 - Science at Work (30 credits)
BI836 - Practical and Applied Research Skills for Advanced Biologists (30 credits)
BI837 - The Molecular and Cellular Basis of Cancer (15 credits)
BI838 - Genomic Stability and Cancer (15 credits)
BI840 - Cancer Therapeutics: From the Laboratory to the Clinic (15 credits)
BI857 - Cancer Research in Focus (15 credits)
BI845 - MSc Project (60 credits)

Assessment

The programme features a combination of examinations and practically focused continuous assessment, which gives you experience within a range of professional activities, eg, report writing, patent applications and public health information. The assessments have been designed to promote employability in a range of professional settings.

Programme aims

This programme aims to:

- provide an excellent quality of postgraduate-level education in the field of cancer, its biology and its treatment

- provide a research-led, inspiring learning environment

- provide a regional postgraduate progression route for the advanced study of a disease that affects a high proportion of the population

- promote engagement with biological research into cancer and inspire you to pursue a scientific career inside or outside of the laboratory

- develop subject specific and transferable skills to maximise employment prospects

- promote an understanding of the impact of scientific research on society and the role for scientists in a range of professions.

Research areas

Research in the School of Biosciences is focused primarily on essential biological processes at the molecular and cellular level, encompassing the disciplines of biochemistry, genetics, biotechnology and biomedical research.

The School’s research has three main themes:

- Protein Science – encompasses researchers involved in industrial biotechnology and synthetic biology, and protein form and function

- Molecular Microbiology – encompasses researchers interested in yeast molecular biology (incorporating the Kent Fungal Group) and microbial pathogenesis

- Biomolecular Medicine – encompasses researchers involved in cell biology, cancer targets and therapies and cytogenomics and bioinformatics.

Each area is led by a senior professor and underpinned by excellent research facilities. The School-led development of the Industrial Biotechnology Centre (IBC), with staff from the other four other schools in the Faculty of Sciences, facilitates and encourages interdisciplinary projects. The School has a strong commitment to translational research, impact and industrial application with a substantial portfolio of enterprise activity and expertise.

Careers

A postgraduate degree in the School of Biosciences is designed to equip our graduates with transferable skills that are highly valued in the workplace. Our research-led ethos ensures that students explore the frontiers of scientific knowledge, and the intensive practical components provide rigorous training in cutting edge technical skills that are used in the modern biosciences while working in areas of world-leading expertise within the School.

Destinations for our graduates include the leading pharmaceutical and biotechnological companies within the UK and leading research institutes both at home and abroad.

Find out how to apply here - https://www.kent.ac.uk/courses/postgraduate/apply-online/226

Read less
This programme aims to provide you with a clear understanding of molecular and cellular biology that is fundamental to cancer biology and cancer research. Read more
This programme aims to provide you with a clear understanding of molecular and cellular biology that is fundamental to cancer biology and cancer research.

You will learn how research in this area has advanced the treatment and diagnoses of cancer, and gain knowledge of how new therapies are developed, evaluated and implemented.

You will gain a thorough knowledge of research methodologies and laboratory techniques, which you will fully utilise in the laboratory research project stage. The valuable research experience you will gain from working with leading cancer experts, will give you a solid foundation upon which a future career in scientific research can be built.

Compulsory Modules

• Biological Therapies
• Cancer Biology
• Cancer Pharmacology
• Drug Development
• Genomic Approaches to Human Diseases
• Molecular Diagnostic & Therapeutics
• Pathology of Cancer
• Research Lab Skills
• Research Methods

Elective Modules

• Cancer Prevention & Screening
• Paediatric & Adolescent Oncology

Core Module for MSc

• Lab project


Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, our programmes are all taught by experts in the field.

To find out more about BCI visit http://www.bci.qmul.ac.uk/study-with-us

Read less
Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies. Read more

Our MRes Experimental Cancer Medicine master's course will give nurses, doctors and clinical researchers the skills needed to work in early phase clinical studies.

You will learn how to master experimental cancer through a combination of traditional teaching and hands-on learning, spending a year as a member of the Experimental Cancer Medicine Team at The Christie while also taking four structured taught units.

The taught units will see you learn the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug into Phase II/III clinical testing.

Alongside the taught elements, you will be allocated to one or more clinical trials that are being conducted by The Christie experimental cancer medicine team. You will have a named trainer and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study.

Nursing and physician students will be expected to participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients.

For clinical trials coordinators, no direct patient contact is envisaged and duties will involve clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research.

You will be able to choose two aspects of your direct clinical trial research experience to write up for your two research projects in a dissertation format. This will give you the skills and knowledge required to critically report medical, scientific and clinically related sciences for peer review.

Aims

The primary purpose of the MRes in Experimental Cancer Medicine is to provide you with the opportunity to work within a premier UK Phase 1 cancer clinical trials unit and, through a mix of taught and experiential learning, master the discipline of Experimental Cancer Medicine.

Special features

Extensive practical experience

You will spend most of your time gaining hands-on experience within The Christie's Experimental Cancer Medicine Team.

Additional course information

Meet the course team

Dr Natalie Cook is a Senior Clinical Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie. She completed a PhD at Cambridge, investigating translational therapeutics and biomarker assay design in pancreatic cancer.

Professor Hughes is Chair of Experimental Cancer Medicine at the University and Strategic Director of the Experimental Cancer Medicine team at The Christie. He is a member of the research strategy group for Manchester Cancer Research Centre. He serves on the Biomarker evaluation review panel for CRUK grant applications.

Professor Hughes was previously Global Vice-President for early clinical development at AstraZeneca, overseeing around 100 Phase 0/1/2 clinical studies. He was previously Global Vice-President for early phase clinical oncology, having been involved in over 200 early phase clinical studies.

Dr Matthew Krebs is a Clinical Senior Lecturer in Experimental Cancer Medicine at the University and Honorary Consultant in Medical Oncology at The Christie.

He has a PhD in circulating biomarkers and postdoctoral experience in single cell and ctDNA molecular profiling. He is Principal Investigator on a portfolio of phase 1 clinical trials and has research interests in clinical development of novel drugs for lung cancer and integration of biomarkers with experimental drug development.

Teaching and learning

Our course is structured around a 2:1 split between clinical-based research projects and taught elements respectively.

Taught course units will predominantly use lectures and workshops.

For the research projects, teaching and learning will take place through one-to-one mentoring from a member of the Experimental Cancer Medicine team.

The clinical and academic experience of contributors to this course will provide you with an exceptional teaching and learning experience.

Coursework and assessment

You will be assessed through oral presentations, single best answer exams, written reports and dissertation.

For each research project, you will write a dissertation of 10,000 to 15,000 words. Examples of suitable practical projects include the following.

Research proposal

  • Compilation of a research proposal to research council/charity
  • Writing a protocol and trial costings for sponsor
  • Research and write a successful expression of interest selected by grant funder for full development

Publication-based/dissertation by publication

  • Writing a clinical study report
  • Authoring a peer-review journal review/original article

Service development/professional report/ report based dissertation

  • Public health report/outbreak report/health needs assessment/health impact assessment
  • Proposal for service development/organisational change
  • Audit/evaluate service delivery/policy
  • Implement recommended change from audit report

Adapted systematic review (qualitative data)

  • Compiling the platform of scientific evidence for a new drug indication from literature
  • Review of alternative research methodologies from literature

Full systematic review that includes data collection (quantitative data)

  • Referral patterns for Phase 1 patients

Qualitative or quantitative empirical research

  • Design, conduct, analyse and report an experiment

Qualitative secondary data analysis/analysis of existing quantitative data

  • Compilation, mining and analysis of existing clinical data sets

Quantitative secondary data analysis/analysis of existing qualitative data/theoretical study/narrative review

  • Policy analysis or discourse analysis/content analysis
  • A critical review of policy using framework analysis

Facilities

Teaching will take place within The Christie NHS Foundation Trust , Withington.

Disability support

Practical support and advice for current students and applicants is available from the Disability Advisory and Support Service. Email: 

Career opportunities

This course is relevant to physician, nursing and clinical research students who are considering a career in Phase 1 clinical studies.

The course provides a theoretical and experiential learning experience and offers a foundation for roles within other experimental cancer medicine centres within the UK and EU, as well as careers in academia, the pharmaceutical industry, clinical trials management and medicine.

The MRes is ideal for high-calibre graduates and professionals wishing to undertake directly channelled research training in the clinical and medical oncology field.



Read less
The area of cancer immunotherapy considers how to use conventional therapies including surgery, radiation and chemotherapy. Read more
The area of cancer immunotherapy considers how to use conventional therapies including surgery, radiation and chemotherapy. Whilst these treatment have served well and new drugs will continue to be designed, clinical trials over the last five years have shown that boosting the body’s immune system, whose main task is to deal with invading pathogens, can help our immune system to destroy tumour cells. Many of the new immunotherapies may be tested in combination with more conventional treatments or tested alone, but investigators and oncologists now believe immunotherapy, initially combined with pharmacological treatments, will soon provide curative therapies and certainly give many patients a new lease of life.

More about this course

Worldwide the incidence of cancer is increasing, and is expected to reach 22 million new cases per year by 2030. In addition to treatments such as radiotherapy and surgery, chemotherapy has a vital role to play in prolonging the lives of patients.

The aims of the Cancer Immunotherapy MSc are to:
-Provide an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving
-Review the biology of cancer with respect to genetics, pathological considerations, and the molecular changes within cells which are associated with the progression of the disease
-Enhance intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data
-Deliver a programme of advanced study to equip students for a future career in anti-cancer drug and immunotherapy development
-Cover new areas in immunotherapy (some of which may enhance existing pharmacological therapies including: History of immunotherapy and review of immune system; Monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; Adoptive T cell therapy; Dendritic cell vaccines; Antibodies that stimulate immunity; Adjuvant development for vaccines; Epigenetics and cancer: improving immunotherapy; Immuno-chemotherapy: integration of therapies; Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis; Dendritic cell vaccine development and Pox virus cancer vaccine vectors; Microbial causes of cancer and vaccination

Students will have access to highly qualified researchers and teachers in pharmacology and immunology, including those at the Cellular and Molecular Immunology Research Centre. Skills gained from research projects are therefore likely to be highly marketable in industry, academia and in the NHS. Students will be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles.

Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

Modular structure

The modules listed below are for the academic year 2016/17 and represent the course modules at this time. Modules and module details (including, but not limited to, location and time) are subject to change over time.

Year 1 modules include:
-Advanced Immunology (core, 20 credits)
-Cancer Immunotherapy (core, 20 credits)
-Cancer Pharmacology (core, 20 credits)
-Cancer: Diagnosis and Therapy (core, 20 credits)
-Molecular Oncology (core, 20 credits)
-Research Project (core, 60 credits)
-Scientific Frameworks for Research (core, 20 credits)

After the course

Students will have many opportunities to work in industry. There are established industries working hard to develop cancer immunotherapies including Bristol-Myers Squibbs, MERCK, AstraZeneca and Roche. There are also an innumerate number of start-up companies appearing including Omnis Pharma, UNUM Therapeutics and Alpine Immune Sciences.

Students will also have ample opportunity for future postgraduate study either within the School of Human Sciences and the Cellular and Molecular Immunology Centre at the MPhil/PhD level or beyond, even with some of our research partners within the UK, Europe and beyond.

Read less
This exciting new course is designed to equip future scientists with the knowledge to make a difference in the understanding and treatment of cancer. Read more
This exciting new course is designed to equip future scientists with the knowledge to make a difference in the understanding and treatment of cancer. The course will take the mechanistic understanding of cancer biology and apply it to the analysis of risk, prevention, diagnosis, prognosis and therapy. Building on a foundation of the understanding of basic cancer cell biology, translational coverage will consider design of treatment modalities, mechanisms of action of anti-cancer drugs, therapy resistance and biomarker discovery. The course will allow the students to gain expertise and knowledge in therapy, cancer chemoprevention, anti-cancer target discovery, clinical trials, imaging, cancer risk and epidemiology and biostatistics. A key component of the course is a five/six-month research project, which will give students an opportunity to study one of these areas in depth.

Read less
This programme aims to respond to a national and international need for clinicians, scientists and allied health professions who can apply a molecular approach to the investigation, diagnosis and management of clinical disease. Read more
This programme aims to respond to a national and international need for clinicians, scientists and allied health professions who can apply a molecular approach to the investigation, diagnosis and management of clinical disease.

We will provide you with theoretical and practical knowledge of modern molecular technologies as applied to human disease, with an emphasis on cancer, and train you in the application and interpretation of advanced molecular technologies.

Compulsory Modules

• Basic Pathology
• Cancer Biology
• Cancer Prevention & Screening
• Genomic Approaches to Human Diseases
• Molecular Diagnostic & Therapeutics
• Molecular Pathology of Solid Tumours
• Research Lab Skills
• Research Methods

Elective Modules

• Introduction to Bioinformatics
• Biological Therapies
• Molecular Targeted Therapies and Immunotherapy for Blood Cancers

Core Modules for MSc

• Lab project



Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, our programmes are all taught by experts in the field.

Find out more about the BCI at http://www.bci.qmul.ac.uk/study-with-us

Read less
The Department of Oncology and the Department for Continuing Education’s CPD Centre offer a part-time MSc in Experimental and Translational Therapeutics that brings together some of Oxford's leading clinicians and scientists to deliver an advanced modular programme designed for those in full-time employment, both in the UK and overseas. Read more

The Department of Oncology and the Department for Continuing Education’s CPD Centre offer a part-time MSc in Experimental and Translational Therapeutics that brings together some of Oxford's leading clinicians and scientists to deliver an advanced modular programme designed for those in full-time employment, both in the UK and overseas.

The Programme draws on the world-class research and teaching in experimental therapeutics at Oxford University and offers a unique opportunity to gain an understanding of the principles that underpin clinical research and to translate this into good clinical and research practice.

Visit the website https://www.conted.ox.ac.uk/about/msc-in-experimental-therapeutics

The deadline for applications is Friday 15 June 2018

If your application is completed by this January deadline and you fulfil the eligibility criteria, you will be automatically considered for a graduate scholarship. For details see: http://www.ox.ac.uk/admissions/graduate/fees-and-funding/graduate-scholarships.

Programme details

The MSc in Experimental and Translational Therapeutics is a part-time course consisting of six modules and a research project and dissertation. The programme is normally completed in two to three years. Students are full members of the University of Oxford and are matriculated as members of an Oxford college.

The modules in this programme can also be taken as individual short courses. It is possible to transfer credit from up to three previously completed modules into the MSc programme, if the time elapsed between commencement of the accredited module(s) and registration for the MSc is not more than two years.

Programme modules:

- The Structure of Clinical Trials and Experimental Therapeutics

- Drug Development, Pharmacokinetics and Imaging

- Pharmacodynamics, Biomarkers and Personalised Therapy

- Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance

- How to do Research on Therapeutic Interventions: Protocol Preparation

- Biological Therapeutics

Course aims

The aim of the MSc programme is to provide students with the necessary training and practical experience to enable them to understand the principles that underpin clinical research, and to enable them to translate that understanding into good clinical and research practice.

By the end of the MSc programme, students should understand the following core principles:

- Development, marketing and regulations of drugs

- Pharmaceutical factors that affect drug therapy

- Pharmacokinetics, pharmacogenetics and pharmacodynamics

- Adverse drug reactions, drug interactions, and pharmacovigilance

- Designing phase I, II and III clinical trials for a range of novel therapeutic interventions (and imaging agents).

- Application of statistics to medicine

- Laboratory assays used to support trial end-points

- Use of non-invasive imaging in drug development

- Application of analytical techniques

By the end of the programme, students should be equipped to:

- demonstrate a knowledge of the principles, methods and techniques for solving clinical research problems and translate this into good clinical and research practice

- apply skills gained in techniques and practical experience from across the medical and biological sciences

- develop skills in managing research-based work in experimental therapeutics

- carry out an extended research project involving a literature review, problem specification and analysis in experimental therapeutics and write a short dissertation

Guidance from the UK Royal College of Physician's Faculty of Pharmaceutical Medicine

The Faculty have confirmed that if enrolled for Pharmaceutical Medicine Specialty Training (PMST), trainees may be able to use knowledge provided by Experimental Therapeutics modules to cover aspects of a module of the PMST curriculum. Trainees are advised to discuss this with their Educational Supervisor.

Experimental Therapeutics modules may also be used to provide those pursuing the Faculty's Diploma in Pharmaceutical Medicine (DPM) with the necessary knowledge required to cover the Diploma syllabus. Applicants for the DPM exam are advised to read the DPM syllabus and rules and regulations.

Members of the Faculty of Pharmaceutical Medicine who are registered in the Faculty's CPD scheme can count participation in Experimental Therapeutics modules towards their CPD record. Non-members may wish to obtain further advice about CPD credit from their Royal College or Faculty.

Assessment methods

To complete the MSc, students need to:

Attend the six modules and complete an assessed written assignment for each module.

Complete a dissertation on a topic chosen in consultation with a supervisor and the Course Director.

Dissertation:

The dissertation is founded on a research project that builds on material studied in the taught modules. The dissertation should normally not exceed 15,000 words.

The project will normally be supervised by an academic supervisor from the University of Oxford, and an employer-based mentor.

The following are topics of dissertations completed by previous students on the course:

- The outcomes of non-surgical management of tubal pregnancy; a 6 month study of the South East London population

- Analysis of the predictive and prognostic factors of outcome in a cohort of patients prospectively treated with perioperative chemotherapy for adenocarcinoma of the stomach or of the gastroesophageal junction

- Evolution of mineral and bone disorder in early Chronic Kidney Disease (CKD): the role of FGF23 and vitamin D

- Survey of patients' knowledge and perception of the adverse drug reporting scheme (yellow cards) in primary care

- The predictive role of ERCC1 status in oxaliplatin based Neoadjuvant for metastatic colorectal cancer (CRC) to the liver

- Endothelial Pathophysiology in Dengue - Dextran studies during acute infection

- Literature review of the use of thalidomide in cancer

- An investigation into the phenotypical and functional characteristics of mesenchymal stem cells for clinical application

- Identification of genetic variants that cause capecitabine and bevacizumab toxicity

- Bridging the evidence gap in geriatric medicines via modelling and simulations

Teaching methods

The class-based modules will include a period of preparatory study, a week of intensive face-to-face lectures and tutorials, followed by a period for assignment work. Attendance at modules will be a requirement for study. Some non-classroom activities will be provided at laboratory facilities elsewhere in the University. The course will include taught material on research skills. A virtual learning environment (VLE) will provide between-module support.

The taught modules will include group work, discussions, guest lectures, and interaction and feedback with tutors and lecturers. Practical work aims to develop the students' knowledge and understanding of the subject.

Find out how to apply here - http://www.ox.ac.uk/admissions/graduate/applying-to-oxford



Read less
Improved global life expectancy has resulted in a cancer epidemic. It is well recognised that accurate early diagnosis is an essential aspect of the administration of increasingly expensive and tailored cancer treatment care plans. Read more
Improved global life expectancy has resulted in a cancer epidemic. It is well recognised that accurate early diagnosis is an essential aspect of the administration of increasingly expensive and tailored cancer treatment care plans.

The Biomedical Sciences (Cancer Biology) MSc programme has been devised to provide knowledge of key aspects of this increasingly important disease area.

You will become familiar with the genetic and cellular changes occurring in both solid and blood-borne cancers, the current and emerging technological approaches for diagnosis of the disease and the effect on pertinent cellular changes on patient prognosis. Studies on populations and the influence of genotypic variation will ensure that you are qualified to make sense of cancer statistics.

You are able to tailor your programme by selecting from a menu of option modules and pursuing a research project in an area ranging from molecular through to cellular or tissue-based aspects of cancer.

During the course you will join our thriving research environment and will have access to excellent laboratory facilities within the Faculty. On successful completion of the course you will be equipped to take forward your career with an in-depth knowledge of this increasingly common disease area.

Modules

The following modules are indicative of what you will study on this course.

Core modules
-ADVANCED CANCER BIOLOGY
-CELL SIGNALLING AND GENETICS
-MOLECULAR SCIENCE AND DIAGNOSTICS
-POSTGRADUATE PROJECT
-POSTGRADUATE RESEARCH METHODS

Option modules
-COMMUNICATING SCIENCE
-EXTENDED POSTGRADUATE PROJECT
-IMMUNOPATHOLOGY
-IMMUNOTHERAPY
-MOLECULAR AND CELLULAR THERAPEUTICS
-SYSTEMS BIOLOGY

Associated careers

After graduation, you will be equipped with the skills and knowledge to pursue a range of cancer-focused careers including appointments in diagnostic laboratories, academic, biotechnological and pharmaceutical research.

As a graduate of this course, you will be ideally placed to play an essential role in both diagnosis and improved care of cancer patients. Opportunities are also available to pursue a career in clinical trials and in areas such as data analysis and public health.

Professional recognition

The course is accredited by the Institute of Biomedical Science (IBMS).

Read less
This exciting interdisciplinary MSc programme focuses on providing advanced academic training in the cellular and molecular processes that relate to the production of biomedicines for use in healthcare. Read more
This exciting interdisciplinary MSc programme focuses on providing advanced academic training in the cellular and molecular processes that relate to the production of biomedicines for use in healthcare.

This is coupled with rigorous practical training in the design, production and characterisation of biomolecules using state-of-theart biotechnological and bioengineering analytical and molecular technologies.

You acquire practical, academic and applied skills in data analysis, systems and modelling approaches, and bioinformatics, together with transferable skills in scientific writing, presentation and public affairs. On successful completion of the programme, you will be able to integrate these skills to develop novel solutions to modern biotechnological issues from both academic and industrial perspectives.

Visit the website: https://www.kent.ac.uk/courses/postgraduate/213/biotechnology-and-bioengineering

About the School of Biosciences

The School of Biosciences is among the best-funded schools of its kind in the UK, with current support from the BBSRC, NERC, MRC, Wellcome Trust, EU, and industry. It has 38 academic staff, 56 research staff (facility managers, research fellows, postdoctoral researchers and technicians), approximately 100 postgraduate students and 20 key support staff. The school's vibrant atmosphere has expanded to become a flourishing environment to study for postgraduate degrees in a notably friendly and supportive teaching and research environment.

Research in the School of Biosciences revolves around understanding systems and processes in the living cell. It has a strong molecular focus with leading-edge activities that are synergistic with one another and complementary to the teaching provision. Our expertise in disciplines such as biochemistry, microbiology and biomedical science allows us to exploit technology and develop groundbreaking ideas in the fields of genetics, molecular biology, protein science and biophysics. Fields of enquiry encompass a range of molecular processes from cell division, transcription and translation through to molecular motors, molecular diagnostics and the production of biotherapeutics and bioenergy.

In addition to research degrees, our key research strengths underpin a range of unique and career-focused taught Master’s programmes that address key issues and challenges within the biosciences and pharmaceutical industries and prepare graduates for future employment.

Course structure

The MSc in Biotechnology and Bioengineering involves studying for 120 credits of taught modules, as indicated below. The taught component takes place during the autumn and spring terms, while a 60-credit research project take place over the summer months.

The programme is taught by staff from the Industrial Biotechnology Centre, an interdisciplinary research centre whose aim is to solve complex biological problems using an integrated approach to biotechnology and bioengineering. It is administered by the School of Biosciences who also contribute to the programme.

Modules

The following modules are indicative of those offered on this programme. This list is based on the current curriculum and may change year to year in response to new curriculum developments and innovation. Most programmes will require you to study a combination of compulsory and optional modules. You may also have the option to take modules from other programmes so that you may customise your programme and explore other subject areas that interest you.

BI830 - Science at Work (30 credits)
BI836 - Practical and Applied Research Skills for Advanced Biologists (30 credits)
BI852 - Advanced Analytical and Emerging Technologies for Biotechnology and Bio (30 credits)
BI857 - Cancer Research in Focus (15 credits)
CB612 - New Enterprise Startup (15 credits)
CB613 - Enterprise (15 credits)
BI840 - Cancer Therapeutics: From the Laboratory to the Clinic (15 credits)
BI845 - Research project (60 credits)

Assessment

Assessment is by coursework and the research project.

Programme aims

You will gain the following transferable skills:

- the ability to plan and manage workloads

- self-discipline and initiative

- the development of reflective learning practices to make constructive use of your own assessment of performance and use that of colleagues, staff and others to enhance performance and progress

- communication: the ability to organise information clearly, create and respond to textual and visual sources (eg images, graphs, tables), present information orally, adapt your style for different audiences.

- enhanced understanding of group work dynamics and how to work as part of a group or independently.

Research areas

Research in the School of Biosciences is focused primarily on essential biological processes at the molecular and cellular level, encompassing the disciplines of biochemistry, genetics, biotechnology and biomedical research.

The School’s research has three main themes:

- Protein Science – encompasses researchers involved in industrial biotechnology and synthetic biology, and protein form and function

- Molecular Microbiology – encompasses researchers interested in yeast molecular biology (incorporating the Kent Fungal Group) and microbial pathogenesis

- Biomolecular Medicine – encompasses researchers involved in cell biology, cancer targets and therapies and cytogenomics and bioinformatics.

Each area is led by a senior professor and underpinned by excellent research facilities. The School-led development of the Industrial Biotechnology Centre (IBC), with staff from the other four other schools in the Faculty of Sciences, facilitates and encourages interdisciplinary projects. The School has a strong commitment to translational research, impact and industrial application with a substantial portfolio of enterprise activity and expertise.

Careers

A postgraduate degree in the School of Biosciences is designed to equip our graduates with transferable skills that are highly valued in the workplace. Our research-led ethos ensures that students explore the frontiers of scientific knowledge, and the intensive practical components provide rigorous training in cutting edge technical skills that are used in the modern biosciences while working in areas of world-leading expertise within the School.

Destinations for our graduates include the leading pharmaceutical and biotechnological companies within the UK and leading research institutes both at home and abroad.

Find out how to apply here - https://www.kent.ac.uk/courses/postgraduate/apply-online/213

Read less
This research-based course has a taught component that is the same as an MSc. It provides a springboard into a career that involves a working knowledge of scientific research. Read more

This research-based course has a taught component that is the same as an MSc. It provides a springboard into a career that involves a working knowledge of scientific research.

The course is designed for graduates with a BSc in the life sciences or other science disciplines, and for intercalating and fully qualified MBBS or BDS students. It can be taken either as a stand-alone qualification or as an entry route onto a PhD or MD.

What you'll learn

The taught component of the course includes subject-specific content in the area of translational medicine and therapeutics. You have the flexibility to develop your own bespoke course by selecting additional, complementary modules. You will also participate in training in general research principles, and other professional and key skills.

Subject-based modules in translational medicine and therapeutics provide the opportunity to learn about the development and evaluation of new medicines and to develop skills in translational research relating to therapeutics. Teaching and supervision is provided by both university-based academics and experts from the pharmaceutical industry.

Your project

Your research project comprises the major element of the course. This project will involve 24 weeks of research in an area of translational medicine and therapeutics under the supervision of an expert academic researcher in the field.

The course allows you to experience an internationally competitive research area, predominantly in academia but also potentially in industry.

Our MRes courses

Translational Medicine and Therapeutics MRes is closely linked to a suite of MRes courses that you may also be interested in:

Faculty of Medical Sciences Graduate School

Our Medical Sciences Graduate School is dedicated to providing you with information, support and advice throughout your research degree studies. We can help and advise you on a variety of queries relating to your studies, funding or welfare.

Our Research Student Development Programme supports and complements your research whilst developing your professional skills and confidence.

You will make an on-going assessment of your own development and training needs through personal development planning (PDP) in the ePortfolio system. Our organised external events and development programme have been mapped against the Vitae Researcher Development Framework to help you identify how best to meet your training and development needs.



Read less
OVERVIEW. The. Oncology Drug Discovery MSc. course is designed to provide an insight into how existing and future drug targets are identified from biological samples isolated from the cancer clinic. Read more

OVERVIEW

The Oncology Drug Discovery MSc course is designed to provide an insight into how existing and future drug targets are identified from biological samples isolated from the cancer clinic. This will include an industrial viewpoint into what makes an interesting target and how, through an iterative process, this target is validated. In addition, lectures will be provided to discuss how ‘hit’ compounds are identified, in both the academic and industrial setting, using compound screen assays and fragment based screening technologies. We will also provide an insight in computational methods for generating chemical ‘hits’. The module will also cover how these ‘hit’ compounds are prosecuted into tool compounds or Lead Optimisation candidates (LO), both historic and modern, that are used to further validate a potential drug target.

During this second module we will provide an insight into the challenges of moving a compound from an LO candidate to a pre-clinical candidate. How bio-marker companion tests are developed, validated and are used to underpin clinical trials. The lectures will also provide a keen insight into novel formulation strategies currently under development within Queen’s University Belfast. In addition, we will also provide an insight into the development of bio-therapeutics, such as antibodies, that are proving to be a powerful alternative to small molecule based therapeutics.

For further information email  or send us a message on WhatsApp

ONCOLOGY DRUG DISCOVERY HIGHLIGHTS

The strong links between us and the biotech and bio-pharmaceutical sectors provides a stimulating translational environment, while also expanding your career opportunities.

GLOBAL OPPORTUNITIES

INDUSTRY LINKS

  • Research projects will be provided by both academic staff and local biotech companies in ground-breaking research areas with a strong focus on clinical applications.

WORLD CLASS FACILITIES

  • The Oncology Drug Discovery course will be taught and mentored within the Centre for Cancer Research and Cell Biology: a purpose-built institute at the heart of the Health Sciences Campus, boasting state-of-the-art research facilities.

INTERNATIONALLY RENOWNED EXPERTS

  • We have an international reputation in this area, achieved through: high-impact peer review publications significant international research funding, the establishment of successful spin-out companies.

 

COURSE STRUCTURE

Research Project

  • You will undertake a lab based project in a number of different facets of the drug development, such as hit identification, hit compound development and therapeutic antibody development pathway working with both academic and biotech groups.Semester 1

Research Translational: from Concept to Commercialisation (Full Year)

  • This module covers the principles of disease biology and new technological developments that increase our understanding of disease processes. It develops an appreciation of the importance of innovation, business awareness and leadership skills in the translation of discovery science to clinical implementation.

Diagnosis and Treatment of Cancer

  • This module provides a comprehensive overview of the diagnosis and treatment of the common solid and haematological malignancies, including breast, ovarian, genitourinary and gastrointestinal cancers as well as the leukaemias

Cancer Biology

  • This module provides a comprehensive overview of the fundamental principles of carcinogenesis, highlighting how normal control processes are bypassed during tumour formation. The pathogenic mechanisms to be discussed will range from genomic alterations in key gene families, to epigenetic mechanisms of gene control, alterations in kinase activities or protein turnover, or activation of aberrant phenotypes such as invasion and angiogenesis.Semester 2

Target Identification and Development in Drug Discovery

  • This module describe how novel drug targets are identified and validated and identifies how biochemical assays are developed and employed in the drug discovery process. It also evaluates the alternative approaches used in the drug discovery to identify new chemical matter. It describes and defines chemical approaches used in developing ‘hit’ chemical compounds and identifies drug target classes and their drug-like pharmacophores.

Drug optimization, drug delivery and clinical trials

  • This module evaluates the issues associated the drug development process and describes the development, validation and use of bio-markers in the drug discovery process. It discusses the practices employed in clinical trials and defines the processes employed in licensing of new chemical equity and the role it plays in the drug discovery process.

For further information email  or send us a message on WhatsApp



Read less
This flexible, part-time Masters level programme for practicing hospital pharmacists is evidence based with a problem-solving, practice-orientated approach. Read more
This flexible, part-time Masters level programme for practicing hospital pharmacists is evidence based with a problem-solving, practice-orientated approach. A full blend of flexible work-based learning supported through web-based learning resources, online discussion and face-to-face learning events creates a rich learning environment. Choosing a Postgraduate Certificate, Diploma, MSc or CPD option will help improve your professional status, developing your career prospects.

Designed with extensive input of a multi-professional team, Bath’s programme reflects the latest developments and challenges. It offers flexibility allowing you to tailor study to suit your situation, with a choice of specialised qualifications in Clinical Pharmacy Practice or Prescribing and Therapeutics enabling you to practise as an Independent Prescriber.

Choose from nearly 20 units

(can be studied separately for CPD)

● Professional skills development (Core Unit)
● Using Evidence in Practice (Core Unit)
● Palliative Care
● Cardiovascular Therapeutics
● Infections
● Mental Health
● Respiratory Therapeutics
● Gastro-Intestinal Therapeutics
● Prescribing for Special Groups
● Prescribing in Context
● Consultation Skills for Prescribing
● Prescribing Effectively
● Neurology
● Oncology
● Endocrinology
● Public Health Pharmacy
● Management of Minor Ailments
● Practice-based research
● Masters dissertation

Programme features

- Choice of awards reflecting your area of professional interest
- Study at your own pace with minimal time away from work
- Excellent support and learner networks with a user-friendly virtual learning environment
- Increased professional expertise and status with enhanced career prospects
- Support in meeting CPD requirements of the GPhC and professional development in line with the RPS Faculty frameworks

Available Qualifications & Duration

CPD course (three months)
PG Certificate (one year part-time)
PG Diploma (two years part-time)
MSc (three years part-time)

Please note all PG Certificate, PG Diploma and MSc students are registered for the maximum study duration of eight years, to allow flexible study options where appropriate.

Visit the website http://www.bath.ac.uk/study/pg/programmes/clin-phar-prac-seco-care/

Pathways

- Clinical Pharmacy Practice (Secondary Care)
- Prescribing & Therapeutics

You can study combinations of units to accumulate credit toward a named award.

Course information

Information about available units and the programme structure can be found in our postgraduate programme brochure (http://www.bath.ac.uk/study/pg/programmes/clin-phar-prac-seco-care/bath-diploma-course-guide-2015.pdf).

Programme descriptions can be found in the University’s online programme catalogue (http://www.bath.ac.uk/catalogues/other.html).

Our research

Research in our Department is centred around a number of focused areas or themes. To find out more, please see our:
- Departmental research webpages (http://www.bath.ac.uk/pharmacy/research/)

Our research staff and students are also involved in a number of formal Research Centres and networks:

Bath Inflammation/Rheumatology Research Network (BIRD)
Cancer Research at Bath ([email protected])
Centre for Extremophile Research
Centre for Mathematical Biology
Centre for Regenerative Medicine (CRM)
Inter-Departmental Infection and Immunity Network
Neuroscience Network at University of Bath (NNUB)
ReMedDes

Find out about the department here - http://www.bath.ac.uk/pharmacy/

Find out how to apply here - http://www.bath.ac.uk/study/pg/apply/index.html

Read less

Show 10 15 30 per page



Cookie Policy    X